India Court Rules Natco CL Of Bayer Drug Does Not Extend To Exports
This article was originally published in PharmAsia News
Executive Summary
The Delhi High Court ruled the India government's grant of a compulsory license for Natco Pharma to market a generic of Bayer's Nexavar (sorafenib) for treating kidney and liver cancers did not carry a right to export it.